Cargando…
Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes
INTRODUCTION: Signal transducer and activator of transcripton-5a (Stat5a) and its close homologue, Stat5b, mediate key physiological effects of prolactin and growth hormone in mammary glands. In breast cancer, loss of nuclear localized and tyrosine phosphorylated Stat5a/b is associated with poor pro...
Autores principales: | Peck, Amy R, Witkiewicz, Agnieszka K, Liu, Chengbao, Klimowicz, Alexander C, Stringer, Ginger A, Pequignot, Edward, Freydin, Boris, Yang, Ning, Ertel, Adam, Tran, Thai H, Girondo, Melanie A, Rosenberg, Anne L, Hooke, Jeffrey A, Kovatich, Albert J, Shriver, Craig D, Rimm, David L, Magliocco, Anthony M, Hyslop, Terry, Rui, Hallgeir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053108/ https://www.ncbi.nlm.nih.gov/pubmed/23036105 http://dx.doi.org/10.1186/bcr3328 |
Ejemplares similares
-
Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment
por: Yang, Ning, et al.
Publicado: (2013) -
Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms
por: Peck, Amy R, et al.
Publicado: (2016) -
Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression
por: Sato, Takahiro, et al.
Publicado: (2013) -
Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism
por: Goodman, C R, et al.
Publicado: (2016) -
Selection of optimal quantile protein biomarkers based on cell-level immunohistochemistry data
por: Yi, Misung, et al.
Publicado: (2023)